4381664
iTRAQ® Reagent - Multiplex Buffer Kit
Synonym(e):
isobaric tags for relative and absolute quantitation, buffer kit
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
UNSPSC-Code:
12161503
NACRES:
NA.25
Empfohlene Produkte
Versandbedingung
dry ice
Lagertemp.
−20°C
Allgemeine Beschreibung
Contains SDS – Denaturant, TCEP Reducing Reagent, MMTS Cysteine Blocking Reagent, TEAB Buffer and Isopropanol, sufficient material for either two 8-plex Multiplex Kits, three 4-plex Kits, or four mTRAQ® 10 Assay Kits.
The iTRAQ® Reagents are a set of isobaric, multiplexed, amine-specific, stable-isotope reagents that can label all peptides in up to eight different biological samples at the same time, allowing for simultaneous identification and quantitation, both relative and absolute, while preserving important post-translational modification (PTM) information. The iTRAQ® reagents can be used to study the differential expression of proteins in perturbed systems.
Anwendung
iTRAQ® Reagent - Multiplex Buffer Kit has been used in the isobaric tag for relative and absolute quantitation (iTRAQ) labeling of protein samples.
Hinweis zur Analyse
To view the Chemistry Quick Reference Card for the iTRAQ® Reagents, please visit this Chemistry Quick Reference Card link.
Rechtliche Hinweise
MTraq is a registered trademark of AB Sciex Pte. Ltd.
iTraq is a registered trademark of AB Sciex Pte. Ltd.
Signalwort
Danger
H-Sätze
Gefahreneinstufungen
Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3
Zielorgane
Central nervous system
Lagerklassenschlüssel
3 - Flammable liquids
Flammpunkt (°F)
53.6 °F - closed cup
Flammpunkt (°C)
12.0 °C - closed cup
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Kunden haben sich ebenfalls angesehen
Lynn R Zieske
Journal of experimental botany, 57(7), 1501-1508 (2006-04-01)
Proteomic research includes the characterization of protein mixtures in order to understand complex biological systems and determine relationships between proteins, their function, and protein-protein interactions. Often the goal of such research is to monitor changes of proteins in perturbed systems
Hongmei Lu et al.
Clinical proteomics, 16, 33-33 (2019-08-07)
Diabetic nephropathy is the most frequent cause of end-stage renal disease worldwide. Identification of biomarkers for diabetic nephropathy for early diagnosis may be the key to avoiding damage from this condition. Proteomic iTRAQ technology was first used to identify differentially
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.